Matheson advised Auxilium Pharmaceuticals Inc. on its $2.6 billion merger with Endo International plc. The transaction, which was announced on 9 October 2014, has been unanimously approved by the boards of directors of both companies. The transaction is valued at USD 2.6 billion, including the repayment and assumption of debt. The deal is expected to close in H1 2015 and is subject to shareholder and regulatory approval. More >>
Tags: Matheson | DublinKirkland & Ellis Advises Blackstone Energy Partners in $700M Equity Commitment to Windy Cove Energy
Kirkland & Ellis LLP advised Blackstone Energy Partners in its $700M equity commitment to Windy Cove Energy LLC to acquire and develop carbon dioxide-enhanced oil recovery properties in the United States. Windy Cove is a newly formed oil and gas company based in Houston, TX. More >>
Tags: Kirkland & Ellis LLP | HonoluluHerbert Smith Freehills advises Regis Healthcare Limited on its A$485.8 million Initial Public Offering
Herbert Smith Freehills has advised Regis Healthcare Limited (Regis) on its successful A$485.8 million initial public offering (IPO) on the Australian Securities Exchange, with shares in Regis closing 10% higher than the offer price on the opening day of trading. More >>
Tags: Herbert Smith Freehills Kramer LLP | Melbourne | SydneySchiff Hardin Enters Dallas Market, Adding New Corporate and Securities, Finance Lawyers
Schiff Hardin LLP, a leading national law firm, today announced it is expanding its platform with a new office in Dallas. The office will be anchored by five accomplished finance, corporate and securities partners. They will occupy temporary space at 1717 McKinney Avenue in Dallas, while the firm secures an office capable of accommodating an expanding local presence. Celebrating its 150th Anniversary in 2014, Schiff Hardin now comprises more than 400 attorneys across eight offices located throughout the United States. More >>
Tags: Schiff Hardin LLP | DallasAkin Gump Advises GE Capital on Secondary Fund Sale
Akin Gump advised GE Capital on the $1.3 billion sale of more than 300 private equity, venture capital and other private fund interest to Ardian (formerly AXA Private Equity), in one of the largest secondary fund portfolio sales of the year. More >>
Tags: Akin Gump Strauss Hauer & Feld LLP | WashingtonAllen & Overy bolsters Africa presence with South Africa launch
Allen & Overy today announces a significant investment in its Africa platform with the launch of an office in Johannesburg, South Africa. This makes Allen & Overy the first of the global elite law firms to establish a presence on the ground in South Africa.
The Johannesburg office will comprise a team of leading South African lawyers, led by partner Lionel Shawe and Michael Duncan, one of the City of London’s leading banking lawyers and former head of A&O’s banking practice, who will be relocating to Johannesburg. More >>
Tags: Allen & Overy LLP | JohannesburgMove Signs Agreement to Sell to News Corp for $950 Million
Cooley is advising Move, Inc. on its $950 million pending sale to News Corporation. The deal is the largest acquisition thus far for News Corp, according to The Wall Street Journal.
Move is a leading online real estate business that operates the real estate listings sites Realtor.com and Move.com. Publishing company News Corp owns The Wall Street Journal and Dow Jones Newswires. The acquisition is said to accelerate News Corp’s digital and global expansion by making online real estate a powerful component of its portfolio. More >>
Tags: Palo Alto | Silicon ValleyDLA Piper represents lululemon in acquisition of significant stake by Advent
DLA Piper represented lululemon athletica inc., a company that creates yoga-inspired athletic apparel, in connection with a transaction through which Advent International, a global private equity firm, acquired a 14 percent stake in lululemon from Chip Wilson, the company’s founder, for US$845 million. More >>
Tags: DLA Piper | New York | SeattleGlobal Law Office advises Wuzhou International Holdings Limited on its offering of USD100,000,000 convertible notes
Goodwin Procter Advises Gallus BioPharmaceuticals in Sale to DPx Holdings
Goodwin Procter attorneys recently advised Gallus BioPharmaceuticals in its sale to DPx Holdings, parent company of Patheon, DSM Fine Chemicals and Banner Life Sciences. Goodwin also advised financial sponsor Ridgemont Equity Partners of Charlotte, N.C. and the senior management team of Gallus in the transaction. The transaction closed on September 29, 2014. More >>
Tags: Goodwin Procter LLP | Boston | Washington







